Hangzhou Haoyue Personal Care (605009) Fundamentals 2026 — P/E 22.4x, Revenue Analysis | SniperIQ
Hangzhou Haoyue Personal Care (605009) is a CN-listed Consumer Defensive company in Household & Personal Products with a market capitalization of ¥5.1B, trading at ¥23.49 on the SHH. This SniperIQ fundamentals page covers Hangzhou Haoyue Personal Care's valuation (P/E 22.4x, P/B 1.4x), profitability (net margin 5.9%), revenue (¥3.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Hangzhou Haoyue Personal Care's market cap?
Hangzhou Haoyue Personal Care (605009) has a market capitalization of approximately ¥5.1B, trading at ¥23.49 on the SHH. Market cap moves with the live share price.
What is Hangzhou Haoyue Personal Care's P/E ratio?
Hangzhou Haoyue Personal Care's trailing twelve-month P/E ratio is 22.4x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Hangzhou Haoyue Personal Care?
Hangzhou Haoyue Personal Care runs a net profit margin of 5.9%, a gross margin of 31.2%, and an operating margin of 7.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Hangzhou Haoyue Personal Care generate?
Hangzhou Haoyue Personal Care reported revenue of ¥3.8B for fiscal year 2025, with net income of ¥232M and earnings per share (EPS) of 1.08. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Hangzhou Haoyue Personal Care pay a dividend?
Hangzhou Haoyue Personal Care offers a trailing dividend yield of about 3.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Hangzhou Haoyue Personal Care financially healthy?
Hangzhou Haoyue Personal Care carries a debt-to-equity ratio of 0.26x and a current ratio of 1.68x, with a market beta of 0.29. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Hangzhou Haoyue Personal Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Hangzhou Haoyue Personal Care (605009) the key facts are: market cap ¥5.1B, P/E 22.4x, revenue ¥3.8B, 52-week range 21.37-43.59. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Hangzhou Haoyue Personal Care's full fundamentals live
Get Hangzhou Haoyue Personal Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.